GB201710414D0 - Chemotherapy - Google Patents

Chemotherapy

Info

Publication number
GB201710414D0
GB201710414D0 GBGB1710414.2A GB201710414A GB201710414D0 GB 201710414 D0 GB201710414 D0 GB 201710414D0 GB 201710414 A GB201710414 A GB 201710414A GB 201710414 D0 GB201710414 D0 GB 201710414D0
Authority
GB
United Kingdom
Prior art keywords
chemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1710414.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Priority to GBGB1710414.2A priority Critical patent/GB201710414D0/en
Publication of GB201710414D0 publication Critical patent/GB201710414D0/en
Priority to PCT/GB2018/051811 priority patent/WO2019002869A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB1710414.2A 2017-06-29 2017-06-29 Chemotherapy Ceased GB201710414D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1710414.2A GB201710414D0 (en) 2017-06-29 2017-06-29 Chemotherapy
PCT/GB2018/051811 WO2019002869A1 (en) 2017-06-29 2018-06-28 Chemotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1710414.2A GB201710414D0 (en) 2017-06-29 2017-06-29 Chemotherapy

Publications (1)

Publication Number Publication Date
GB201710414D0 true GB201710414D0 (en) 2017-08-16

Family

ID=59592476

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1710414.2A Ceased GB201710414D0 (en) 2017-06-29 2017-06-29 Chemotherapy

Country Status (2)

Country Link
GB (1) GB201710414D0 (en)
WO (1) WO2019002869A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832686A (en) * 1986-06-24 1989-05-23 Anderson Mark E Method for administering interleukin-2
GB0307011D0 (en) 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
CN1302770C (en) * 2004-12-17 2007-03-07 辽宁正鑫药物研究有限公司 Gel of chlormethine hydrochloride and preparing method
MX2009000660A (en) 2006-07-17 2009-04-08 Glaxosmithkline Biolog Sa Influenza vaccine.
GB0701896D0 (en) 2007-02-01 2007-03-14 Regentec Ltd Composition
GB0903810D0 (en) 2009-03-05 2009-04-22 Regentec Ltd Delivery system
US10189773B2 (en) * 2010-05-07 2019-01-29 Medicus Biosciences, Llc In-vivo gelling pharmaceutical pre-formulation
US10028997B2 (en) * 2014-06-04 2018-07-24 Geisinger Health System Systems and methods for attracting and trapping brain cancer cells
CN106822913B (en) * 2017-01-22 2020-03-13 中国科学院长春应用化学研究所 Complex, preparation method thereof and hydrogel

Also Published As

Publication number Publication date
WO2019002869A1 (en) 2019-01-03

Similar Documents

Publication Publication Date Title
DK3606954T3 (en) Anti-LAG3-antistoffer
DK3734167T3 (en) Airconditionsystem
GB201703129D0 (en) Quibbler
GB201716073D0 (en) Moeco
DK3499914T3 (en) Høreapparatsystem
DK3700925T3 (en) Hidtil ukendt t-cellereceptor
DK3615457T3 (en) Transportcontainer
AU201714106S (en) Mandoline
DK3485765T3 (en) Computerbord
DK3630041T3 (en) Stimulationsapparat
DK3401557T3 (en) Træskrue
GB201700825D0 (en) Poliovaccine
DK3718525T3 (en) Motoriseret asssistancesystem
DK3704866T3 (en) Datatransmissionssystem
GB201702641D0 (en) Easpagnolette
GB201710414D0 (en) Chemotherapy
DK3425793T3 (en) Tagsystem
DK3618761T3 (en) Intrakorporalt perfusionssystem
DK3351149T3 (en) Syltetøjsfontæne
AU201715236S (en) Striplight
AP00994S1 (en) Autorickshaw
GB201704353D0 (en) Superswoosher
GB201704262D0 (en) Shop-a-box
GB201703643D0 (en) Drydam
GB201703539D0 (en) Tech-Form

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)